Nephrology Doctors in Edinburg, TX Accepting Medicare

4 Nephrology doctors found. Showing 1 - 4

Dr. Jayanth Kadur Lakshmikanth, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5501 S Mccoll Rd, Edinburg, TX 78539 Phone: 956-360-8677    Fax: 956-362-7253

Dr. Marco Bruno Thierry, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 5501 S Mccoll Rd, Edinburg, TX 78539 Phone: 956-362-8677

Dr. Mahmoud Barazi, M.D. Internal Medicine - Nephrology Medicare: May Accept Medicare Assignments Practice Location: 502 S Closner Blvd, Edinburg, TX 78539 Phone: 956-292-0100

Andrew Levine, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4717 S Sugar Rd, Ste. H, Edinburg, TX 78539 Phone: 956-383-4041    Fax: 956-383-4183

News Archive

South Africa, Lesotho, Swaziland form alliance to fight MDR-TB

Health ministers from Lesotho, Swaziland and South Africa said they have formed an alliance to fight drug-resistant tuberculosis, Deutsche Presse-Agentur/M&C reports.

Gene panel is effective at identifying problematic genes in common leukemia

A gene panel that looks for about 10 times the number of cancer-causing genes as panels currently used to diagnose and fine-tune treatment for a variety of cancers is effective at identifying problematic genes in the most common leukemia, investigators report.

Amgen starts Phase 3 study assessing the benefit of Kyprolis in patients with relapsed/refractory multiple myeloma

Amgen today announced the initiation of the ARROW trial, a global Phase 3 study evaluating the benefit of Kyprolis® (carfilzomib) for Injection administered once-weekly with dexamethasone versus the current U.S. Food and Drug Administration (FDA) approved twice-weekly administration schedule in patients with relapsed and refractory multiple myeloma who have received prior treatment with bortezomib and an immunomodulatory agent (IMiD).

First COPD patient treated with RejuvenAir System in a multicenter clinical trial

Temple University Hospital has treated the first patient in a multicenter international clinical trial utilizing the RejuvenAir System for the treatment of patients suffering from moderate to severe chronic obstructive pulmonary disease with chronic bronchitis.

Women are less likely than men to receive care in trauma center after severe injury

Women are less likely than men to receive care in a trauma center after severe injury, according to a new study of almost 100,000 Canadian patients.

Read more Medical News

› Verified 6 days ago